CXCR4 and glioma: Therefore, a pilot phase I/II trial (NCT01977677) studied the side effects and best dose of Plerixafor (a CXCR4 inhibitor) after radiation therapy plus TMZ to see how well it works in treating patients with newly diagnosed high-grade glioma.